164 results
10-K
2023 FY
EX-10.7
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
10-K
2023 FY
EX-10.6
BTAX
Biostax Corp.
Annual report
15 Apr 24
8:32pm
8-K
EX-10.1
BTAX
Biostax Corp.
13 Sep 23
Departure of Directors or Certain Officers
5:16pm
8-K
EX-10.3
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.1
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.2
9yyrklyabnw3fg
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.2
hjps ekopz
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
hckludaum9 qzq0
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
hycrql8q46l
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-10.1
d9qt0uvmlvghm2x as34
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-10.1
cpgh08 d019mnn
7 Jul 22
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-10.1
9jcogo 5rfu
2 Jun 21
Other Events
9:00am